Melanoma News and Research

Latest Melanoma News and Research

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma.

4 Oct 2023

Is ChatGPT ready to be your next medical advisor?

Vanderbilt University researchers explored ChatGPT's potential in medical information provision to professionals and patients. While showing promise in delivering accurate, comprehensive medical insights, the need for continuous algorithm refinement and better source discernment were highlighted to fully harness ChatGPT's potential.

3 Oct 2023

Gene variants linked to higher risk for nodular melanoma identified

Researchers from The University of Queensland and The Alfred hospital in Melbourne have identified gene variants which may contribute to people being at higher risk for nodular melanoma.

3 Oct 2023

Metabolism-targeting drug could offer new hope for cancer-related fatigue

Cancer-related fatigue (CRF) is a debilitating yet all-too-common condition, which can severely affect quality of life for patients undergoing treatment.

3 Oct 2023

Mobile AI rivals specialists in diagnosing skin cancer, outperforms junior doctors

This multicenter clinical trial compared AI-powered mobile phone diagnostic tools with human medical experts in diagnosing pigmented skin cancer. The study found that the AI system was equivalent to specialists in accuracy and superior to novices, showcasing mobile technology's potential for accessible and accurate skin cancer diagnosis.

28 Sep 2023

Neoadjuvant immunotherapy shows promise in multiple cancer types

Treating cancer with immunotherapies known as an immune checkpoint blockade (ICB) prior to surgery (so-called neoadjuvant immunotherapy) has been a rapidly growing area of research, but the scientific community is just scratching the surface of what is possible, according to a review article co-authored by several current and former investigators from the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Kimmel Cancer Center.

28 Sep 2023

New approach could improve immune checkpoint inhibitor response in MTAP-deficient tumors

Loss of the "housekeeping" gene methylthioadenosine phosphorylase, or MTAP, is a common event in cancer.

28 Sep 2023

Discovery sheds new light on the chain of events in early embryonic development

A new discovery by researchers challenges our current understanding of gastrulation, the most important stage of early embryonic development.

27 Sep 2023

New form of cellular immunotherapy shows promise against brain tumors in mice

Scientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) successfully tested a new form of cellular immunotherapy against brain tumors in mice for the first time.

26 Sep 2023

Everyday chemicals linked to increased cancer risk, especially in women

This study identifies links between exposure to chemicals like PFAS, parabens, and phenols and increased cancer risk, particularly among women and across racial groups. The findings spotlight the role of environmental toxins in hormone-related cancers, suggesting new avenues for cancer prevention and mitigation strategies.

24 Sep 2023

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

A comprehensive review in Signal Transduction and Targeted Therapy delves into the versatility and effectiveness of mRNA vaccines, from their game-changing role in COVID-19 to potential applications in cancer and rare diseases. Despite drawbacks like stability and high immunogenicity, advancements in vaccine technology have poised mRNA platforms as a robust tool for both preventive and therapeutic interventions.

21 Sep 2023

Manipulating mitochondrial electron flow enhances immune response, reduces tumor growth

Immunotherapy, which uses the body's own immune system to fight cancer, is an effective treatment option, yet many patients do not respond to it.

21 Sep 2023

Scientists uncover potential key risk factors for melanomas in children and adolescents

A recent eBioMedicine study found key risk factors associated with the development of melanoma in children and adolescents.

19 Sep 2023

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

A recent review in the journal Immunity delves into the crucial role of dendritic cells (DCs) in shaping T-cell responses in cancer, highlighting their importance in both priming anti-tumor immunity and in ongoing immune interactions within tumors. The findings underscore the potential of DCs as key targets for next-generation cancer immunotherapies.

18 Sep 2023

How does the APOE4 gene play both hero and villain in your health risks?

The study reveals that APOE4, a genetic risk factor for Alzheimer's Disease and cardiovascular diseases, has complex effects on mortality risk. While APOE4 carriers with higher AD neuropathology have increased mortality risk, those with low neuropathology had a reduced risk of certain cancers, warranting further research into this genetic factor's diverse impact on health outcomes.

14 Sep 2023

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Today, the American Association for Cancer Research (AACR) released the 13th edition of its annual Cancer Progress Report, which chronicles how basic, translational, and clinical cancer research and cancer-related population sciences-;primarily supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI)-;remain vitally important to improving health and saving lives.

13 Sep 2023

Is there an association between the COVID-19 pandemic and cancer incidence?

The COVID-19 pandemic influenced cancer incidence.

8 Sep 2023

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

The COVID-19 pandemic led to a notable decline in new cancer diagnoses in Manitoba, Canada, particularly affecting breast, colon, and rectal cancers. The study highlights the urgent need for healthcare strategies to mitigate the impact of future disruptions on cancer detection and treatment.

6 Sep 2023

New research could help improve the effectiveness of immunotherapy for people with brain tumors

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread to the brain from other parts of the body respond to immunotherapy while glioblastoma, an aggressive cancer that originates in the brain, does not.

1 Sep 2023

Higher-income individuals at increased risk of melanoma in Atlantic Canada, study finds

A new study led by McGill University examines why people living in Atlantic regions are more at-risk for developing melanoma than other Canadians, providing lessons on skin cancer prevention for the whole country.

31 Aug 2023

Melanoma News and Research

Latest Melanoma News and Research

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

Is ChatGPT ready to be your next medical advisor?

Gene variants linked to higher risk for nodular melanoma identified

Metabolism-targeting drug could offer new hope for cancer-related fatigue

Mobile AI rivals specialists in diagnosing skin cancer, outperforms junior doctors

Neoadjuvant immunotherapy shows promise in multiple cancer types

New approach could improve immune checkpoint inhibitor response in MTAP-deficient tumors

Discovery sheds new light on the chain of events in early embryonic development

New form of cellular immunotherapy shows promise against brain tumors in mice

Everyday chemicals linked to increased cancer risk, especially in women

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

Manipulating mitochondrial electron flow enhances immune response, reduces tumor growth

Scientists uncover potential key risk factors for melanomas in children and adolescents

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

How does the APOE4 gene play both hero and villain in your health risks?

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Is there an association between the COVID-19 pandemic and cancer incidence?

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

New research could help improve the effectiveness of immunotherapy for people with brain tumors

Higher-income individuals at increased risk of melanoma in Atlantic Canada, study finds

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Melanoma News and Research

Latest Melanoma News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in